Imbed Biosciences

Imbed Biosciences, headquartered in Madison, Wisconsin, specializes in developing and manufacturing fully synthetic antimicrobial wound care products. The company’s portfolio includes Surgaflex™, an ultrathin antimicrobial polymer matrix for acute and surgical wounds; PelashieldAM™, a hydrophilic antimicrobial matrix designed for burn wounds; and Microlyte® Matrix, a unique synthetic skin substitute clinically proven to improve healing in chronic wounds. All products are fully synthetic, containing no human or animal-derived tissues or cells, and are designed to provide a consistent biocompatible matrix, supply non-toxic antimicrobial benefits, and maintain an ideal moisture environment for wound healing. Imbed Biosciences is registered with the U.S. FDA as a medical device manufacturer and maintains an ISO 13485 certified Quality Management System. The company was founded by a group of physicians and scientists at the University of Wisconsin-Madison. It has received a Technology Breakthrough designation for PelashieldAM™ and a Skin Integrity and Wound Care agreement with Premier, Inc. Additionally, Microlyte® Matrix is categorized by CMS as a synthetic skin substitute with an assigned billing code of A2005.